Primary Job Title Managing Director Primary Organization 
Hamilton BioVentures
Gender Male
Investor Type
Dr. Dance has 25 years of executive experience, both as a scientist and a leader, and has focused on life sciences since the beginning the formation of Hamilton in 1998. Dr. Dance came to San Diego in 1978 and became President of General Atomics Corporation. While at General Atomics he founded an in-house venture enterprise (one of the first in San
Diego) which produced a successful track record and spun off several successful enterprises, including the San Diego Super Computer Center.
Dr. Kerry Dance currently is the Chairman of the Board of Directors of Angstrom Pharmaceuticals, is a Director of PhotoThera and observes on the Board of Ceregene. He was a founding Board member of Egea Biosciences and was actively involved in direction of the company as well as its sale to J&J in 2004. Dr. Dance was also heavily involved in the sourcing of PhotoThera and Q3DM and served on the Boards of Directors for both of these companies during the crucial early years. Dr. Dance led the due diligence on Ceregene and was able to bring both MPM Capital and Alta Partners into a $32 million first venture capital financing round for Ceregene with a guaranteed position for Hamilton in the round. He has previously served as CEO of Advanced Distillation Technology, a seawater desalination company, as well as President of the S-Cubed Division of Maxwell Laboratories, Inc., and Vice President of Technology for Aerojet General Corporation.
Dr. Dance attended Stanford University where he received a Ph.D. in Mechanical Engineering with a Nuclear Option and Math Minor and B.S. and M.S. degrees in Engineering Science
